-
21
-
22
-
23
-
24
Engineering tomato disease resistance by manipulating susceptibility genes
Published 2025-02-01Get full text
Article -
25
-
26
-
27
-
28
-
29
-
30
The cell as secret agent—autonomy and intelligence of the living cell: driving force of development
Published 2023-10-01Get full text
Article -
31
Mackinawite partial oxidation to green rust produces a large, abiotic uranium isotope fractionation
Published 2025-02-01Get full text
Article -
32
-
33
-
34
-
35
-
36
Clinical Burden and Healthcare Resource Use of Asthma in Children in the UK
Published 2025-02-01“…Imène Gouia,1 Florence Joulain,1 Yi Zhang,2 Christopher Ll Morgan,3 Asif H Khan4 1HEVA (Health Economics and Value Assessment), Sanofi, Gentilly, France; 2Medical Affairs, Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA; 3Epidemiology, Pharmatelligence Ltd, Cardiff, UK; 4Global Medical, Sanofi, Bridgewater, NJ, USACorrespondence: Imène Gouia, Sanofi, 82 Avenue Raspail, Gentilly Cedex, 94255, France, Tel +33786980603, Email Imene.Gouia@sanofi.comBackground: UK pediatric asthma prevalence is among the highest in Europe, and although the clinical and economic burden of asthma in UK adults is well described, childhood asthma data is lacking. …”
Get full text
Article -
37
Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study
Published 2016-12-01Get full text
Article